Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159247 · ClinicalTrials.gov registry record · NA
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
A NA study of Glaucoma and Medication Adherence, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT03159247 is a NA study of Glaucoma and Medication Adherence that has completed, run by University of Michigan. The registered enrollment target is 107 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03159247, a NA study of Glaucoma and Medication Adherence, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the impact of two personalized technology based programs that may help improve adherence to glaucoma medications.
Conditions Studied
Interventions
- BEHAVIORAL eyeGuide
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-01-12 |
| Est. Completion | 2020-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03159247
The ClinicalTrials.gov registry entry for NCT03159247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (88% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which eyeGuide is the first listed.
NCT03159247 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03159247 about?
NCT03159247 is a clinical study titled "The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program". The purpose of this research study is to test the impact of two personalized technology based programs that may help improve adherence to glaucoma medications.
What is the current status of trial NCT03159247?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-01-12. Estimated completion is 2020-01-10.
What conditions does trial NCT03159247 study?
This clinical trial studies the following conditions: Glaucoma, Medication Adherence.
What interventions are being tested in trial NCT03159247?
The interventions under investigation include: eyeGuide (BEHAVIORAL).
Who is sponsoring clinical trial NCT03159247?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03159247 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.